Trypanosoma cruzi: IL-10, TNF, IFN-γ and IL-12 regulate innate and acquired immunity to infection

Experimental Parasitology

Volumn 84, Issue 2, 1996, Pages 231-244

  Abrahamsohn, Ises A ^a   Coffman, Robert L ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; HOST PARASITE INTERACTION; HOST RESISTANCE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030298134     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1996.0109     Document Type: Article

References (41)

1. ABRAHAMSOHN, I. A., AND COFFMAN, R. L. 1995. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. Journal of Immunology 155, 3955-3963.
2. ALIBERTI, J. C. S., CARDOSO, M. A. G., MARTINS, G. A., GAZINELLI, R. T., VIEIRA, L. Q., AND SILVA, J. S. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. In press Infection and Immunity 64, 1961-1967.
3. + lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cellular Immunology, 170, 41-53.
4. BERG, D. J., KUHN, R., RAJEWSKY, K., MULLER, W., MENON, S., DAVIDSON, N., GRUNIG, G., AND RENNICK, D. 1995. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. Journal of Clinical Investigation 96, 2339-2347.
5. BIRON, C. A., AND GAZINELLI, R. T. 1995. IL-12 effects on immune responses to microbial infections in regulating disease outcome. Current Opinion in Immunology 7, 485-496.
6. BRENER, Z. 1962. Therapeutic activity and criterion of cure on mice experimentally infected with T. cruzi. Revista de Instituto de Medicina Tropical de S. Paulo 4, 389-395.
7. CARDILLO, F., VOLTARELLI, J. C., REED, S. G., AND SILVA, J. S. 1996. Regulation of Trypanosoma cruzi infection in mice by gamma Interferon and interleukin 10: role of NK cells. Infection and Immunity 64, 128-134.
8. CUROTTO-DE-LAFAILLE, M. A., BARBOSA-DE-OLIVEIRA, L. C., LIMA, G. C., AND ABRAHAMSOHN, I. A. 1990. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Experimental Parasitology 70, 164-174.
9. DE-TITTO, E. H., CATTERALL, J. R., AND REMINGTON, J. S. 1986. Activity of recombinant tumor necrosis factor on Taxoplasma gondii and Trypanosoma cruzi. Journal of Immunology 137, 1342-1345.
10. FLESCH, I. E., AND KAUFMANN, S. H. 1994. Role of macrophages and alpha-beta T lymphocytes in early interleukin 10 production during Listeria monocytogenes infection. International Immunology 6, 463-468.
11. GATELY, M. K., WARRIER, R. R., HONASOGE, S., CARVAJAL, D. M., FAHERTY, D. M., CONNAUGHTON, S. E., ANDERSON, T. D., SARMIENTO, U., HUBBARD, B. R., AND MURPHY, M. 1994. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. International Immunology 6, 157-167.
12. GAZZINELLI, R. T., OSWALD, I. P., HIENY, S., JAMES, S. L., AND SHER, A. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxidemediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. European Journal of Immunology 22, 2501-2506.
13. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. Journal of Immunology 157, 798-805.
14. GOLDEN, J. M., AND TARLETON, R. L. 1991. Trypanosoma cruzi: Cytokine effects on macrophage trypanocidal activity. Experimental Parasitology 72, 391-402.
15. HOFT, D. F., LYNCH, R. G., AND KIRCHHOFF, L. V. 1993. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. Journal of Immunology 151, 7038-7047.
16. KIERSZENBAUM, F., AND SZTEIN, M. B. 1994. Chagas' Disease (American Trypanosomiasis). In "Parasitic Infections and the Immune System" (F. Kierszenbaum, Ed.), pp. 53-85. Academic Press, San Diego.
17. KÜHN, R., LÖHLER, J., RENNICK, D., RAJEWSKI, K., AND MÜLLER, W. 1993. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75, 263-274.
18. MINOPRIO, P., EL-CHEIKH, M. C., MURPHY, E., HONTEBEYRIE-JOSKOWICS, M., COFFMAN, R., COUTINHO, A., AND O'GARRA, A. 1993. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. Journal of Immunology 151, 4200-4208.
19. MOSMANN, T. R. 1994. Properties and functions of interleukin-10. Advances in Immunology 56, 1-26.
20. MUNOZ-FERNANDEZ, M. A., FERNANDEZ, M. A., AND FRESNO, M. 1992. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. European Journal of Immunology 22, 301-307.
21. NABORS, G. S., AND TARLETON, R. L. 1991. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. Journal of Immunology 146, 3591-3598.
22. NICKELL, S. P., STRYKER, G. A., AND AREVALO, C. 1993. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. Journal of Immunology 150, 1446-1457.
23. OLIVARES-FONTT, E., AND VRAY, B. 1995. Relationship between granulocyte macrophage-colony stimulating factor, tumour necrosis factor-alpha and Trypanosoma cruzi infection of murine macrophages. Parasite Immunology 17, 135-141.
24. PETRAY, P. B., ROTTENBERG, M. E., BERTOT, G., CORRAL, R. S., DIAZ, A., ORN, A., AND GRINSTEIN, S. 1993. Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunology Letters 35, 77-80.
25. PLATA, F., WIETZERBIN, J., PONS, F. G., FALCOFF, E., AND EISEN, H. 1984. Synergistic protection by specific antibodies and Interferon against infection by Trypanosoma cruzi in vitro. European Journal of Immunology 14, 930-935.
26. REED, S. G. 1988. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. Journal of Immunology 140, 4342-4347.
27. REED, S. G., BROWNELL, C. E., RUSSO, D. M., SILVA, J. S., GRABSTEIN, K. H., AND MORRISSEY, P. J. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. Journal of Immunology 153, 3135-3140.
28. REED, S. G., NATHAN, C. F., PIHL, D. L., RODRICKS, P., SHANEBECK, K., CONLON, P. J., AND GRABSTEIN, K. H. 1987. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide: Comparison with interferon gamma. Journal of Experimental Medicine 166, 1734-1746.
29. ROTTENBERG, M. E., RIARTE, A., SPORRONG, L., ALTCHEH, J., PETRAY, P., RUIZ, A. M., WIGZELL, H., AND ORN, A. 1995. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CDS. Immunology Letters 45, 53-60.
30. SHER, A., AND COFFMAN, R. L. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annual Review of Immunology 10, 385-409.
31. SILVA, J. S., MORRISSEY, P. J., GRABSTEIN, K. H., MOHLER, K. M., ANDERSON, D., AND REED, S. G. 1992. Interleukin 10 and Interferon gamma regulation of experimental Trypanosoma cruzi infection. Journal of Experimental Medicine 175, 169-174.
32. SILVA, J. S., TWARDZIK, D. R., AND REED, S. G. 1991. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta). Journal of Experimental Medicine 174, 539-545.
33. SILVA, J. S., VESPA, G. N., CARDOSO, M. A., ALIBERTI, J. C., AND CUNHA, F. Q. 1995. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infection and Immunity 63, 4862-4867.
34. TARLETON, R. L. 1988. Tumor necrosis factor (cachectin) production during experimental Chagas' disease. Clinical and Experimental Immunology 73, 186-190.
35. TARLETON, R. L., KOLLER, B. H., LATOUR, A., AND POSTAN, M. 1992. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356, 338-340.
36. TORRICO, F., HEREMANS, H., RIVERA, M. T., VAN-MARCK, E., BILLIAU, A., AND CARLIER, Y. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology. 146, 3626-3632.
37. TRINCHIERI, G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annual Review of Immunology 13, 251-276.
38. WIRTH, J. J., AND KIERSZENBAUM, F. 1988. Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin. Journal of Immunology 141, 286-288.
39. WIRTH, J. J., KIERSZENBAUM, F., SONNENFELD, G., AND ZLOTNIK, A. 1985. Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi. Infection and Immunity 49, 61-66.
40. WIRTH, J. J., KIERSZENBAUM, F., AND ZLOTNIK, A. 1989. Effects of IL-4 on macrophage functions: Increased uptake and killing of a protozoan parasite (Trypanosoma cruzi). Immunology 66, 296-301.
41. ZHANG, L., AND TARLETON, R. L. 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: Lack of association between susceptibility and type 2 cytokine production. European Journal of Immunology 26, 102-109.